Weeks 8-12+: Plateau and Maintenance The 8-12 week mark represents the plateau phase where most glutathione effects reach their peak measurable level
Participants with a history of or who were currently undergoing treatment for serious illnesses (malignant tumors, heart failure, or myocardial infarction) and those with pacemakers or implantable defibrillators, cardiac arrhythmia, hepatic disease, renal disease, cerebrovascular disease, rheumatism, diabetes mellitus, dyslipidemia, hypertension, hepatitis B, hepatitis C, or other chronic diseases were excluded from the trial
This helps us make any needed changes
Critical illness Tesamorelin labeling warns about increased mortality observed with pharmacologic GH in acute critical illness and advises considering discontinuation in critically ill patients